Fairmount Funds Management Llc Magenta Therapeutics, Inc. (MGTA) insider trading activity

Fairmount Funds Management LLC Transaction History

Date	Transaction	Value	Shares Traded
Sep 27 2024	SELL Other acquisition or disposition	-	62,146
Apr 01 2024	SELL Other acquisition or disposition	-	58,857
Apr 01 2024	BUY Other acquisition or disposition	-	58,857
Jan 22 2024	BUY Grant, award, or other acquisition	$10,012,008 $12.0 p/Share	834,334
Sep 29 2023	BUY Open market or private purchase	$336,252 $13.63 p/Share	24,670
Sep 26 2023	BUY Open market or private purchase	$394,500 $13.15 p/Share	30,000
Sep 19 2023	BUY Open market or private purchase	$396,000 $13.2 p/Share	30,000
Sep 13 2023	BUY Open market or private purchase	$110,155 $11.76 p/Share	9,367
Sep 12 2023	BUY Open market or private purchase	$161,523 $10.85 p/Share	14,887

COGT

Cogent Biosciences, Inc. Healthcare

VRDN

Viridian Therapeutics, Inc.\DE Healthcare

Director

APGE

Apogee Therapeutics, Inc.

Director

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

ABIO

ARCA biopharma, Inc. Healthcare

Director

ZBIO

Zenas BioPharma, Inc.

Director

FFM

Director

Philadelphia, PA

Receive a notification when an Institution or Guru buys or sells MGTA shares.

Notify only if

Value

Get notified when an Magenta Therapeutics, Inc. insider buys or sells MGTA shares.

Notify only if

Operation

Value

Type

Receive news related to Magenta Therapeutics, Inc.